{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,2]],"date-time":"2026-11-02T22:07:56Z","timestamp":1793657276007,"version":"4.5.1"},"reference-count":108,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,8,1]],"date-time":"2026-08-01T00:00:00Z","timestamp":1785542400000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,6,16]],"date-time":"2026-06-16T00:00:00Z","timestamp":1781568000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Bone Oncology"],"published-print":{"date-parts":[[2026,8]]},"DOI":"10.1016\/j.jbo.2026.100777","type":"journal-article","created":{"date-parts":[[2026,6,19]],"date-time":"2026-06-19T16:31:33Z","timestamp":1781886693000},"page":"100777","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":2,"special_numbering":"C","title":["Extracellular vesicles in osteosarcoma: bridging resistance, immunity, and clinical translation"],"prefix":"10.1016","volume":"59","author":[{"given":"Baile","family":"Mao","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lin","family":"An","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"XianJun","family":"Shao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.jbo.2026.100777_bb0005","doi-asserted-by":"crossref","unstructured":"Beird HC, Bielack SS, Flanagan AM, Gill J, Heymann D, Janeway KA, et al. Osteosarcoma. Nat. Rev. Dis. Primers 2022;8(1):77.","DOI":"10.1038\/s41572-022-00409-y"},{"key":"10.1016\/j.jbo.2026.100777_bb0010","doi-asserted-by":"crossref","unstructured":"Wessel KM, Janeway KA, Davis LE, Drezner N, Donoghue M, Helman LJ. Considerations for clinical trial design in relapsed and refractory osteosarcoma: an FDA symposium. Clin. Cancer Res. 2026.","DOI":"10.1158\/1078-0432.CCR-25-3282"},{"key":"10.1016\/j.jbo.2026.100777_bb0015","doi-asserted-by":"crossref","unstructured":"Lilienthal I, Herold N. Targeting molecular mechanisms underlying treatment efficacy and resistance in osteosarcoma: a review of current and future strategies. Int. J. Mol. Sci. 2020;21(18).","DOI":"10.3390\/ijms21186885"},{"issue":"6","key":"10.1016\/j.jbo.2026.100777_bb0020","doi-asserted-by":"crossref","first-page":"630","DOI":"10.1200\/JCO.23.01367","article-title":"Survival trends among adolescents and young adults diagnosed with Cancer in the United States: comparisons with children and older adults","volume":"42","author":"Keegan","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.jbo.2026.100777_bb0025","doi-asserted-by":"crossref","unstructured":"Iacobescu GL, Corlatescu AD, Costin HP, Spiridonica R, Popa MI, Cirstoiu C. Molecular and glycosylation pathways in osteosarcoma: tumor microenvironment and emerging strategies toward personalized oncology. Curr. Issues Mol. Biol. 2025;47(8).","DOI":"10.3390\/cimb47080629"},{"issue":"7","key":"10.1016\/j.jbo.2026.100777_bb0030","doi-asserted-by":"crossref","first-page":"4208","DOI":"10.1097\/JS9.0000000000001340","article-title":"Comparison of oncological and functional outcomes in lower-limb osteosarcoma pediatric patients: a large single-center retrospective cohort study","volume":"110","author":"Xu","year":"2024","journal-title":"Int. J. Surg. (London, England)."},{"key":"10.1016\/j.jbo.2026.100777_bb0035","doi-asserted-by":"crossref","unstructured":"Bull EC, Singh A, Harden AM, Soanes K, Habash H, Toracchio L, et al. Targeting metastasis in paediatric bone sarcomas. Mol. Cancer 2025;24(1):153.","DOI":"10.1186\/s12943-025-02365-z"},{"key":"10.1016\/j.jbo.2026.100777_bb0040","doi-asserted-by":"crossref","unstructured":"Ramos A, Sadeghi S, Tabatabaeian H. Battling chemoresistance in cancer: root causes and strategies to uproot them. Int. J. Mol. Sci. 2021;22(17).","DOI":"10.3390\/ijms22179451"},{"key":"10.1016\/j.jbo.2026.100777_bb0045","doi-asserted-by":"crossref","unstructured":"Yarapureddy S, Abril J, Foote J, Kumar S, Asad O, Sharath V, et al. ATF6\u03b1 activation enhances survival against chemotherapy and serves as a prognostic indicator in osteosarcoma. Neoplasia 2019;21(6):516\u201332.","DOI":"10.1016\/j.neo.2019.02.004"},{"issue":"4","key":"10.1016\/j.jbo.2026.100777_bb0050","doi-asserted-by":"crossref","first-page":"259","DOI":"10.1038\/s41388-022-02529-x","article-title":"The strategy and clinical relevance of in vitro models of MAP resistance in osteosarcoma: a systematic review","volume":"42","author":"Tippett","year":"2023","journal-title":"Oncogene"},{"key":"10.1016\/j.jbo.2026.100777_bb0055","doi-asserted-by":"crossref","unstructured":"Kinnaman MD, Zaccaria S, Makohon-Moore A, Arnold B, Levine MF, Gundem G, et al. Subclonal somatic copy-number alterations emerge and dominate in recurrent osteosarcoma. Cancer Res. 2023;83(22):3796\u2013812.","DOI":"10.1158\/0008-5472.CAN-23-0385"},{"key":"10.1016\/j.jbo.2026.100777_bb0060","doi-asserted-by":"crossref","unstructured":"Li J, Hu J, Yang Y, Zhang H, Liu Y, Fang Y, et al. Drug resistance in cancer: molecular mechanisms and emerging treatment strategies. Mol. Biomed. 2025;6(1):111.","DOI":"10.1186\/s43556-025-00352-w"},{"key":"10.1016\/j.jbo.2026.100777_bb0065","doi-asserted-by":"crossref","unstructured":"Taylor AM, Sheng J, Ng PKS, Harder JM, Kumar P, Ahn JY, et al. Immunosuppressive tumor microenvironment of osteosarcoma. Cancers (Basel) 2025;17(13).","DOI":"10.3390\/cancers17132117"},{"issue":"24","key":"10.1016\/j.jbo.2026.100777_bb0070","doi-asserted-by":"crossref","first-page":"5630","DOI":"10.1158\/1078-0432.CCR-24-1854","article-title":"Large-scale comparative analysis of canine and human osteosarcomas uncovers conserved clinically relevant tumor microenvironment subtypes","volume":"30","author":"Patkar","year":"2024","journal-title":"Clinical cancer research\u202f: an official journal of the American Association for Cancer Research."},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0075","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1186\/s12943-024-02105-9","article-title":"Advances on immunotherapy for osteosarcoma","volume":"23","author":"Yu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbo.2026.100777_bb0080","doi-asserted-by":"crossref","unstructured":"Mu H, Zhang Q, Zuo D, Wang J, Tao Y, Li Z, et al. Methionine intervention induces PD-L1 expression to enhance the immune checkpoint therapy response in MTAP-deleted osteosarcoma. Cell Rep. Med. 2025;6(3):101977.","DOI":"10.1016\/j.xcrm.2025.101977"},{"key":"10.1016\/j.jbo.2026.100777_bb0085","doi-asserted-by":"crossref","unstructured":"Lei ZN, Tian Q, Teng QX, Wurpel JND, Zeng L, Pan Y, et al. Understanding and targeting resistance mechanisms in cancer. MedComm 2023;4(3):e265.","DOI":"10.1002\/mco2.265"},{"key":"10.1016\/j.jbo.2026.100777_bb0090","doi-asserted-by":"crossref","unstructured":"Yan Z, Deng Y, Huang L, Zeng J, Wang D, Tong Z, et al. Biopolymer-based bone scaffold for controlled Pt (IV) prodrug release and synergistic photothermal-chemotherapy and immunotherapy in osteosarcoma. J. Nanobiotechnol. 2025;23(1):286.","DOI":"10.1186\/s12951-025-03253-w"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0095","doi-asserted-by":"crossref","first-page":"1019","DOI":"10.1038\/s42003-025-08409-w","article-title":"Single-cell analysis links DCUN1D5 to immune remodeling and cisplatin resistance in recurrent osteosarcoma","volume":"8","author":"Wu","year":"2025","journal-title":"Commun Biol."},{"key":"10.1016\/j.jbo.2026.100777_bb0100","doi-asserted-by":"crossref","unstructured":"Yue X, Cui J, Ren S, Zhang Y, Li Y, Cui H, et al. NK-cell-derived extracellular vesicles engineered to carry senolytics eliminate chemotherapy-induced senescent osteosarcoma cells. J. Extracell. Vesicles 2025;14(7):e70123.","DOI":"10.1002\/jev2.70123"},{"key":"10.1016\/j.jbo.2026.100777_bb0105","doi-asserted-by":"crossref","unstructured":"Liu W, Li L, Bai X, Zhang M, Lv W, Ma Y, et al. Osteosarcoma cell-derived migrasomes promote macrophage M2 polarization to aggravate osteosarcoma proliferation and metastasis. Adv Sci (Weinh). 2025;12(17):e2409870.","DOI":"10.1002\/advs.202409870"},{"issue":"2","key":"10.1016\/j.jbo.2026.100777_bb0110","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12404","article-title":"Minimal information for studies of extracellular vesicles (MISEV2023): from basic to advanced approaches","volume":"13","author":"Welsh","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0115","doi-asserted-by":"crossref","first-page":"328","DOI":"10.1186\/s13046-023-02886-9","article-title":"Unveiling the role of osteosarcoma-derived secretome in premetastatic lung remodelling","volume":"42","author":"Almeida","year":"2023","journal-title":"Journal of experimental & clinical cancer research\u202f: CR."},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0120","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1186\/s12943-025-02358-y","article-title":"Extracellular vesicles: the \u201ctrojan horse\u201d within breast cancer host microenvironments","volume":"24","author":"Kang","year":"2025","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.jbo.2026.100777_bb0125","doi-asserted-by":"crossref","unstructured":"Weinman MA, Ramsey SA, Leeper HJ, Brady JV, Schlueter A, Stanisheuski S, et al. Exosomal proteomic signatures correlate with drug resistance and carboplatin treatment outcome in a spontaneous model of canine osteosarcoma. Cancer Cell Int. 2021;21(1):245.","DOI":"10.1186\/s12935-021-01943-7"},{"key":"10.1016\/j.jbo.2026.100777_bb0130","doi-asserted-by":"crossref","first-page":"1133726","DOI":"10.3389\/fonc.2023.1133726","article-title":"Exosomes and osteosarcoma drug resistance","volume":"13","author":"Fu","year":"2023","journal-title":"Front. Oncol."},{"issue":"3","key":"10.1016\/j.jbo.2026.100777_bb0135","doi-asserted-by":"crossref","first-page":"659","DOI":"10.1158\/1078-0432.CCR-22-2682","article-title":"Circulating Exosomal PD-L1 at initial diagnosis predicts outcome and survival of patients with osteosarcoma","volume":"29","author":"Wang","year":"2023","journal-title":"Clinical cancer research\u202f: an official journal of the American Association for Cancer Research."},{"key":"10.1016\/j.jbo.2026.100777_bb0140","doi-asserted-by":"crossref","unstructured":"Wang J, Zhang H, Sun X, Wang X, Ren T, Huang Y, et al. Exosomal PD-L1 and N-cadherin predict pulmonary metastasis progression for osteosarcoma patients. J. Nanobiotechnol. 2020;18(1):151.","DOI":"10.1186\/s12951-020-00710-6"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0145","doi-asserted-by":"crossref","first-page":"330","DOI":"10.1186\/s12935-022-02746-0","article-title":"LncRNA XIST from the bone marrow mesenchymal stem cell derived exosome promotes osteosarcoma growth and metastasis through miR-655\/ACLY signal","volume":"22","author":"Zhu","year":"2022","journal-title":"Cancer Cell Int."},{"issue":"11","key":"10.1016\/j.jbo.2026.100777_bb0150","doi-asserted-by":"crossref","first-page":"2103","DOI":"10.1002\/mc.23796","article-title":"M2 macrophage exosome-derived Apoc1 promotes ferroptosis resistance in osteosarcoma by inhibiting ACSF2 deubiquitination","volume":"63","author":"Yin","year":"2024","journal-title":"Mol. Carcinog."},{"key":"10.1016\/j.jbo.2026.100777_bb0155","doi-asserted-by":"crossref","unstructured":"Yang L, Huang X, Guo H, Wang L, Yang W, Wu W, et al. Exosomes as efficient nanocarriers in osteosarcoma: biological functions and potential clinical applications. Front. Cell Dev. Biol. 2021;9:737314.","DOI":"10.3389\/fcell.2021.737314"},{"key":"10.1016\/j.jbo.2026.100777_bb0160","doi-asserted-by":"crossref","first-page":"1002742","DOI":"10.3389\/fimmu.2022.1002742","article-title":"Extracellular vesicles: a new diagnostic biomarker and targeted drug in osteosarcoma","volume":"13","author":"Gao","year":"2022","journal-title":"Front. Immunol."},{"key":"10.1016\/j.jbo.2026.100777_bb0165","doi-asserted-by":"crossref","unstructured":"Strum S, Evdokimova V, Radvanyi L, Spreafico A. Extracellular vesicles and their applications in tumor diagnostics and immunotherapy. Cells 2024;13(23).","DOI":"10.3390\/cells13232031"},{"issue":"5","key":"10.1016\/j.jbo.2026.100777_bb0170","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1016\/j.ymthe.2023.02.021","article-title":"Extracellular vesicles: from bone development to regenerative orthopedics","volume":"31","author":"Davies","year":"2023","journal-title":"Mol. Ther."},{"key":"10.1016\/j.jbo.2026.100777_bb0175","doi-asserted-by":"crossref","unstructured":"Ma Y, Zhang X, Liu C, Zhao Y. Extracellular vesicles in cancers: mechanisms, biomarkers, and therapeutic strategies. MedComm (2020). 2024;5(12):e70009.","DOI":"10.1002\/mco2.70009"},{"key":"10.1016\/j.jbo.2026.100777_bb0180","doi-asserted-by":"crossref","unstructured":"Miceli RT, Chen TY, Nose Y, Tichkule S, Brown B, Fullard JF, et al. Extracellular vesicles, RNA sequencing, and bioinformatic analyses: challenges, solutions, and recommendations. J. Extracell. Vesicles 2024;13(12):e70005.","DOI":"10.1002\/jev2.70005"},{"issue":"13\u201314","key":"10.1016\/j.jbo.2026.100777_bb0185","article-title":"Understanding extracellular vesicle and nanoparticle heterogeneity: novel methods and considerations","volume":"21","author":"Phillips","year":"2021","journal-title":"Proteomics"},{"key":"10.1016\/j.jbo.2026.100777_bb0190","doi-asserted-by":"crossref","unstructured":"Weber B, Ritter A, Han J, Schaible I, Sturm R, Relja B, et al. Development of a sampling and storage protocol of extracellular vesicles (EVs)-establishment of the first EV biobank for polytraumatized patients. Int. J. Mol. Sci. 2024;25(11).","DOI":"10.3390\/ijms25115645"},{"key":"10.1016\/j.jbo.2026.100777_bb0195","doi-asserted-by":"crossref","unstructured":"R\u00edos de Los R\u00edos Res\u00e9ndiz J, Herrmann-Sim F, Wilkesmann L, Helm D, Schneider M, Campione G, et al. A translational protocol optimizes the isolation of plasma-derived extracellular vesicle proteomics. Sci. Rep. 2025;15(1):24292.","DOI":"10.1038\/s41598-025-08366-8"},{"issue":"8","key":"10.1016\/j.jbo.2026.100777_bb0200","doi-asserted-by":"crossref","first-page":"1216","DOI":"10.7150\/ijms.74137","article-title":"Role of extracellular vesicles in osteosarcoma","volume":"19","author":"Yang","year":"2022","journal-title":"Int. J. Med. Sci."},{"key":"10.1016\/j.jbo.2026.100777_bb0205","doi-asserted-by":"crossref","unstructured":"Liao Y, Yi Q, He J, Huang D, Xiong J, Sun W, et al. Extracellular vesicles in tumorigenesis, metastasis, chemotherapy resistance and intercellular communication in osteosarcoma. Bioengineered 2023;14(1):113\u201328.","DOI":"10.1080\/21655979.2022.2161711"},{"key":"10.1016\/j.jbo.2026.100777_bb0210","doi-asserted-by":"crossref","DOI":"10.3389\/fonc.2021.722922","article-title":"Extracellular vesicles in bone Tumors: how to seed in the surroundings molecular information for malignant transformation and progression","volume":"11","author":"Cappariello","year":"2021","journal-title":"Front. Oncol."},{"key":"10.1016\/j.jbo.2026.100777_bb0215","doi-asserted-by":"crossref","unstructured":"Th\u00e9ry C, Witwer KW, Aikawa E, Alcaraz MJ, Anderson JD, Andriantsitohaina R, et al. Minimal information for studies of extracellular vesicles 2018 (MISEV2018): a position statement of the International Society for Extracellular Vesicles and update of the MISEV2014 guidelines. J. Extracell. Vesicles 2018;7(1):1535750.","DOI":"10.1080\/20013078.2018.1461450"},{"issue":"2","key":"10.1016\/j.jbo.2026.100777_bb0220","doi-asserted-by":"crossref","first-page":"397","DOI":"10.1002\/1097-0142(197102)27:2<397::AID-CNCR2820270224>3.0.CO;2-X","article-title":"Cultivation in vitro of cells derived from a human osteosarcoma","volume":"27","author":"McAllister","year":"1971","journal-title":"Cancer"},{"key":"10.1016\/j.jbo.2026.100777_bb0225","doi-asserted-by":"crossref","unstructured":"Luu HH, Kang Q, Park JK, Si W, Luo Q, Jiang W, et al. An orthotopic model of human osteosarcoma growth and spontaneous pulmonary metastasis. Clin. Exp. Metastasis 2005;22(4):319\u201329.","DOI":"10.1007\/s10585-005-0365-9"},{"key":"10.1016\/j.jbo.2026.100777_bb0230","doi-asserted-by":"crossref","unstructured":"Garimella R, Washington L, Isaacson J, Vallejo J, Spence M, Tawfik O, et al. Extracellular membrane vesicles derived from 143B osteosarcoma cells contain pro-osteoclastogenic cargo: a novel communication mechanism in osteosarcoma bone microenvironment. Transl. Oncol. 2014;7(3):331\u201340.","DOI":"10.1016\/j.tranon.2014.04.011"},{"key":"10.1016\/j.jbo.2026.100777_bb0235","doi-asserted-by":"crossref","unstructured":"Guerrero J, Maevskaia E, Pfister P, Dominguez AP, Ghayor C, Bhattacharya I, et al. Mineralized osteoblast-derived exosomes and 3D-printed ceramic-based scaffolds for enhanced bone healing: a preclinical exploration. Acta Biomater. 2025;200:686\u2013702.","DOI":"10.1016\/j.actbio.2025.05.051"},{"key":"10.1016\/j.jbo.2026.100777_bb0240","doi-asserted-by":"crossref","unstructured":"Sheikh IA, Kiela PR, Ghishan FK. Isolation of in vitro osteoblastic-derived matrix vesicles by ultracentrifugation and cell-free mineralization assay. Bio-Protoc. 2025;15(7):e5258.","DOI":"10.21769\/BioProtoc.5258"},{"key":"10.1016\/j.jbo.2026.100777_bb0245","doi-asserted-by":"crossref","unstructured":"Hasegawa T, Hongo H, Yamamoto T, Abe M, Yoshino H, Haraguchi-Kitakamae M, et al. Matrix vesicle-mediated mineralization and osteocytic regulation of bone mineralization. Int. J. Mol. Sci. 2022;23(17).","DOI":"10.3390\/ijms23179941"},{"key":"10.1016\/j.jbo.2026.100777_bb0250","doi-asserted-by":"crossref","unstructured":"Ansari S, de Wildt BWM, Vis MAM, de Korte CE, Ito K, Hofmann S, et al. Matrix vesicles: role in bone mineralization and potential use as therapeutics. Pharmaceuticals (Basel, Switzerland). 2021;vol. 14(4).","DOI":"10.3390\/ph14040289"},{"key":"10.1016\/j.jbo.2026.100777_bb0255","doi-asserted-by":"crossref","unstructured":"Bracht JWP, Los M, van Eijndhoven MAJ, Bettin B, van der Pol E, Pegtel DM, et al. Platelet removal from human blood plasma improves detection of extracellular vesicle-associated miRNA. J. Extracell. Vesicles 2023;12(2):e12302.","DOI":"10.1002\/jev2.12302"},{"key":"10.1016\/j.jbo.2026.100777_bb0260","doi-asserted-by":"crossref","unstructured":"Matamoros-Angles A, Karadjuzovic E, Mohammadi B, Song F, Brenna S, Meister SC, et al. Efficient enzyme-free isolation of brain-derived extracellular vesicles. J. Extracell. Vesicles 2024;13(11):e70011.","DOI":"10.1002\/jev2.70011"},{"key":"10.1016\/j.jbo.2026.100777_bb0265","doi-asserted-by":"crossref","unstructured":"Cao Y, Xu P, Shen Y, Wu W, Chen M, Wang F, et al. Exosomes and cancer immunotherapy: a review of recent cancer research. Front. Oncol. 2022;12:1118101.","DOI":"10.3389\/fonc.2022.1118101"},{"key":"10.1016\/j.jbo.2026.100777_bb0270","doi-asserted-by":"crossref","unstructured":"Fan R, Chen S, Lan F, Li W, Zhu Y, Zhang L, et al. Surface-enhanced Raman scattering (SERS)-based biosensors for advanced extracellular vesicle detection: a review. Anal. Chim. Acta 2025;1336:343264.","DOI":"10.1016\/j.aca.2024.343264"},{"key":"10.1016\/j.jbo.2026.100777_bb0275","doi-asserted-by":"crossref","unstructured":"Han Z, Peng X, Yang Y, Yi J, Zhao D, Bao Q, et al. Integrated microfluidic-SERS for exosome biomarker profiling and osteosarcoma diagnosis. Biosens. Bioelectron. 2022;217:114709.","DOI":"10.1016\/j.bios.2022.114709"},{"key":"10.1016\/j.jbo.2026.100777_bb0280","doi-asserted-by":"crossref","unstructured":"Jin Y, Zhang J, Wu X, Qu C, Fang X, Yang Y, et al. Microfluidics-based label-free SERS profiling of exosomes with machine learning for osteosarcoma diagnosis. Talanta 2025;294:128276.","DOI":"10.1016\/j.talanta.2025.128276"},{"key":"10.1016\/j.jbo.2026.100777_bb0285","doi-asserted-by":"crossref","unstructured":"Diehl JN, Ray A, Collins LB, Peterson A, Alexander KC, Boutros JG, et al. A standardized method for plasma extracellular vesicle isolation and size distribution analysis. PLoS One 2023;18(4):e0284875.","DOI":"10.1371\/journal.pone.0284875"},{"key":"10.1016\/j.jbo.2026.100777_bb0290","doi-asserted-by":"crossref","unstructured":"Ben Fraj S, Naserian S, Lorenzini B, Goulinet S, Mauduit P, Uzan G, et al. Human umbilical cord blood endothelial progenitor cell-derived extracellular vesicles control important endothelial cell functions. Int. J. Mol. Sci. 2023;24(12).","DOI":"10.3390\/ijms24129866"},{"key":"10.1016\/j.jbo.2026.100777_bb0295","doi-asserted-by":"crossref","unstructured":"Zhai C, Xu J, Yang Y, Xie F, Cao L, Wang K, et al. Heterogeneous analysis of extracellular vesicles for osteosarcoma diagnosis. Anal. Chem. 2024;96(23):9486\u201392.","DOI":"10.1021\/acs.analchem.4c00941"},{"key":"10.1016\/j.jbo.2026.100777_bb0300","doi-asserted-by":"crossref","unstructured":"Ji YR, Lee J, Kim H, Kong H, Zhao C, Ju Y, et al. Noninvasive assessment of protease activity in osteosarcoma via click chemistry-mediated enrichment of extracellular vesicles. Adv. Funct. Mater. 2025;35(41).","DOI":"10.1002\/adfm.202422469"},{"key":"10.1016\/j.jbo.2026.100777_bb0305","doi-asserted-by":"crossref","unstructured":"Kie\u0142bowski K, Plewa P, Szulc J, \u0106mil M, Bakinowska E, Pawlik A. Extracellular vesicles and PD-L1-a review of complex immunoregulatory properties and clinical importance. Biomedicines 2025;13(6).","DOI":"10.3390\/biomedicines13061356"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0310","doi-asserted-by":"crossref","first-page":"678","DOI":"10.1186\/s12951-025-03768-2","article-title":"Advances of extracellular vesicles isolation and detection frontier technology: from heterogeneity analysis to clinical application","volume":"23","author":"Li","year":"2025","journal-title":"J Nanobiotechnology."},{"key":"10.1016\/j.jbo.2026.100777_bb0315","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2024.116235","article-title":"Unveiling the role of ferroptosis-associated exosomal non-coding RNAs in cancer pathogenesis","volume":"172","author":"Zhang","year":"2024","journal-title":"Biomed. Pharmacother."},{"key":"10.1016\/j.jbo.2026.100777_bb0320","doi-asserted-by":"crossref","unstructured":"Jiang M, Jike Y, Liu K, Gan F, Zhang K, Xie M, et al. Exosome-mediated miR-144-3p promotes ferroptosis to inhibit osteosarcoma proliferation, migration, and invasion through regulating ZEB1. Mol. Cancer 2023;22(1):113.","DOI":"10.1186\/s12943-023-01804-z"},{"key":"10.1016\/j.jbo.2026.100777_bb0325","doi-asserted-by":"crossref","unstructured":"Du J, Meng X, Yang M, Chen G, Li J, Zhu Z, et al. NGR-modified CAF-derived exos targeting tumor vasculature to induce ferroptosis and overcome chemoresistance in osteosarcoma. Adv. Sci. 2025;vol. 12(12):e2410918.","DOI":"10.1002\/advs.202410918"},{"key":"10.1016\/j.jbo.2026.100777_bb0330","doi-asserted-by":"crossref","unstructured":"Lu H, Zhang J, Shen T, Jiang W, Liu H, Su J. Harnessing artificial intelligence for engineering extracellular vesicles. Extracell Vesicles Circ Nucl Acids. 2025;6(3):522\u201346.","DOI":"10.20517\/evcna.2025.35"},{"key":"10.1016\/j.jbo.2026.100777_bb0335","doi-asserted-by":"crossref","unstructured":"Serretiello E, Smimmo A, Ballini A, Parmeggiani D, Agresti M, Bassi P, et al. Extracellular vesicles and artificial intelligence: unique weapons against breast cancer. Appl. Sci. 2024;14(4):1639.","DOI":"10.3390\/app14041639"},{"issue":"12","key":"10.1016\/j.jbo.2026.100777_bb0340","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1038\/s41568-020-00302-4","article-title":"Non-genetic mechanisms of therapeutic resistance in cancer","volume":"20","author":"Marine","year":"2020","journal-title":"Nat. Rev. Cancer"},{"key":"10.1016\/j.jbo.2026.100777_bb0345","doi-asserted-by":"crossref","unstructured":"Raimondo S, Pucci M, Alessandro R, Fontana S. Extracellular vesicles and tumor-immune escape: biological functions and clinical perspectives. Int. J. Mol. Sci. 2020;21(7).","DOI":"10.3390\/ijms21072286"},{"key":"10.1016\/j.jbo.2026.100777_bb0350","doi-asserted-by":"crossref","unstructured":"Zhang H, Wu B, Wang Y, Du H, Fang L. Extracellular vesicles as mediators and potential targets in combating cancer drug resistance. Molecules 2025;30(3):498.","DOI":"10.3390\/molecules30030498"},{"key":"10.1016\/j.jbo.2026.100777_bb0355","doi-asserted-by":"crossref","unstructured":"Catalano A, Iacopetta D, Ceramella J, Scumaci D, Giuzio F, Saturnino C, et al. Multidrug resistance (MDR): a widespread phenomenon in pharmacological therapies. Molecules 2022;27(3).","DOI":"10.3390\/molecules27030616"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0360","doi-asserted-by":"crossref","first-page":"189","DOI":"10.3892\/ijo.2016.3509","article-title":"Multimodal transfer of MDR by exosomes in human osteosarcoma","volume":"49","author":"Torreggiani","year":"2016","journal-title":"Int. J. Oncol."},{"key":"10.1016\/j.jbo.2026.100777_bb0365","doi-asserted-by":"crossref","unstructured":"Wang X, Qiao D, Chen L, Xu M, Chen S, Huang L, et al. Chemotherapeutic drugs stimulate the release and recycling of extracellular vesicles to assist cancer cells in developing an urgent chemoresistance. Mol. Cancer 2019;18(1):182.","DOI":"10.1186\/s12943-019-1114-z"},{"issue":"4","key":"10.1016\/j.jbo.2026.100777_bb0370","doi-asserted-by":"crossref","first-page":"858","DOI":"10.1002\/cbin.11532","article-title":"Cisplatin-resistant osteosarcoma cell-derived exosomes confer cisplatin resistance to recipient cells in an exosomal circ_103801-dependent manner","volume":"45","author":"Pan","year":"2021","journal-title":"Cell Biol. Int."},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0375","doi-asserted-by":"crossref","first-page":"510","DOI":"10.1186\/s13018-021-02631-y","article-title":"Hsa_circ_0004674 promotes osteosarcoma doxorubicin resistance by regulating the miR-342-3p\/FBN1 axis","volume":"16","author":"Bai","year":"2021","journal-title":"J. Orthop. Surg. Res."},{"issue":"5","key":"10.1016\/j.jbo.2026.100777_bb0380","doi-asserted-by":"crossref","DOI":"10.1016\/j.tranon.2021.101056","article-title":"Chemotherapeutic drugs: cell death- and resistance-related signaling pathways. Are they really as smart as the tumor cells?","volume":"14","author":"Mollaei","year":"2021","journal-title":"Transl. Oncol."},{"key":"10.1016\/j.jbo.2026.100777_bb0385","doi-asserted-by":"crossref","DOI":"10.1016\/j.cellsig.2025.112125","article-title":"Rab27b-mediated CAFs derived exosomal miR-22-3p suppresses ferroptosis and promotes cisplatin resistance in osteosarcoma","volume":"136","author":"Duan","year":"2025","journal-title":"Cell. Signal."},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0390","doi-asserted-by":"crossref","first-page":"308","DOI":"10.1186\/s12935-025-03930-8","article-title":"CAFs exosomal miR-21-5p suppresses ferroptosis and promotes proliferation and migration in osteosarcoma","volume":"25","author":"Niu","year":"2025","journal-title":"Cancer Cell Int."},{"key":"10.1016\/j.jbo.2026.100777_bb0395","doi-asserted-by":"crossref","unstructured":"Huang Y, Liu W, He B, Wang L, Zhang F, Shu H, et al. Exosomes derived from bone marrow mesenchymal stem cells promote osteosarcoma development by activating oncogenic autophagy. J. Bone Oncol. 2020;21:100280.","DOI":"10.1016\/j.jbo.2020.100280"},{"issue":"2","key":"10.1016\/j.jbo.2026.100777_bb0400","doi-asserted-by":"crossref","first-page":"11007","DOI":"10.1080\/21655979.2021.2005220","article-title":"Human umbilical vein endothelial cells derived-exosomes promote osteosarcoma cell stemness by activating notch signaling pathway","volume":"12","author":"Yang","year":"2021","journal-title":"Bioengineered"},{"issue":"20","key":"10.1016\/j.jbo.2026.100777_bb0405","doi-asserted-by":"crossref","first-page":"4714","DOI":"10.1158\/1078-0432.CCR-23-4097","article-title":"Tumor-secreted extracellular vesicles counteract therapy response by triggering inflammatory mesenchymal stem cell development","volume":"30","author":"Massaro","year":"2024","journal-title":"Clinical cancer research\u202f: an official journal of the American Association for Cancer Research."},{"key":"10.1016\/j.jbo.2026.100777_bb0410","doi-asserted-by":"crossref","unstructured":"Wang BD, Yu XJ, Hou JC, Fu B, Zheng H, Liu QK, et al. Bevacizumab attenuates osteosarcoma angiogenesis by suppressing MIAT encapsulated by serum-derived extracellular vesicles and facilitating miR-613-mediated GPR158 inhibition. Cell Death Dis. 2022;13(3):272.","DOI":"10.1038\/s41419-022-04620-3"},{"key":"10.1016\/j.jbo.2026.100777_bb0415","doi-asserted-by":"crossref","unstructured":"Raimondi L, De Luca A, Gallo A, Costa V, Russelli G, Cuscino N, et al. Osteosarcoma cell-derived exosomes affect tumor microenvironment by specific packaging of microRNAs. Carcinogenesis 2020;41(5):666\u201377.","DOI":"10.1093\/carcin\/bgz130"},{"issue":"3","key":"10.1016\/j.jbo.2026.100777_bb0420","doi-asserted-by":"crossref","first-page":"1473","DOI":"10.7150\/thno.51245","article-title":"H3K27 acetylation activated-COL6A1 promotes osteosarcoma lung metastasis by repressing STAT1 and activating pulmonary cancer-associated fibroblasts","volume":"11","author":"Zhang","year":"2021","journal-title":"Theranostics"},{"key":"10.1016\/j.jbo.2026.100777_bb0425","doi-asserted-by":"crossref","unstructured":"Mazumdar A, Urdinez J, Boro A, Migliavacca J, Arlt MJE, Muff R, et al. Osteosarcoma-derived extracellular vesicles induce lung fibroblast reprogramming. Int. J. Mol. Sci. 2020;21(15).","DOI":"10.3390\/ijms21155451"},{"key":"10.1016\/j.jbo.2026.100777_bb0430","doi-asserted-by":"crossref","unstructured":"Silva AKA, Morille M, Piffoux M, Arumugam S, Mauduit P, Larghero J, et al. Development of extracellular vesicle-based medicinal products: a position paper of the group \"extracellular vesicle translatiOn to clinicaL perspectiVEs - EVOLVE France\". Adv. Drug Deliv. Rev. 2021;179:114001.","DOI":"10.1016\/j.addr.2021.114001"},{"key":"10.1016\/j.jbo.2026.100777_bb0435","doi-asserted-by":"crossref","first-page":"479","DOI":"10.1016\/j.addr.2021.04.012","article-title":"A call for the standardised reporting of factors affecting the exogenous loading of extracellular vesicles with therapeutic cargos","volume":"173","author":"Rankin-Turner","year":"2021","journal-title":"Adv. Drug Deliv. Rev."},{"key":"10.1016\/j.jbo.2026.100777_bb0440","doi-asserted-by":"crossref","first-page":"3483","DOI":"10.2147\/IJN.S372851","article-title":"Mesenchymal stem cell derived exosomes as nanodrug carrier of doxorubicin for targeted osteosarcoma therapy via SDF1-CXCR4 Axis","volume":"17","author":"Wei","year":"2022","journal-title":"Int. J. Nanomedicine"},{"key":"10.1016\/j.jbo.2026.100777_bb0445","doi-asserted-by":"crossref","unstructured":"Wei H, Chen J, Wang S, Fu F, Zhu X, Wu C, et al. A nanodrug consisting of doxorubicin and exosome derived from mesenchymal stem cells for osteosarcoma treatment in vitro. Int. J. Nanomedicine 2019;14:8603\u201310.","DOI":"10.2147\/IJN.S218988"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0450","doi-asserted-by":"crossref","first-page":"3291","DOI":"10.1080\/10717544.2022.2141921","article-title":"Exosome mimetics derived from bone marrow mesenchymal stem cells deliver doxorubicin to osteosarcoma in vitro and in vivo","volume":"29","author":"Wang","year":"2022","journal-title":"Drug Deliv."},{"key":"10.1016\/j.jbo.2026.100777_bb0455","doi-asserted-by":"crossref","unstructured":"Chen W, Li Z, Yu N, Zhang L, Li H, Chen Y, et al. Bone-targeting exosome nanoparticles activate Keap1\/Nrf2\/GPX4 signaling pathway to induce ferroptosis in osteosarcoma cells. J. Nanobiotechnol. 2023;21(1):355.","DOI":"10.1186\/s12951-023-02129-1"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0460","doi-asserted-by":"crossref","first-page":"411","DOI":"10.7150\/thno.33482","article-title":"Extracellular vesicle-mediated delivery of miR-101 inhibits lung metastasis in osteosarcoma","volume":"10","author":"Zhang","year":"2020","journal-title":"Theranostics"},{"key":"10.1016\/j.jbo.2026.100777_bb0465","doi-asserted-by":"crossref","unstructured":"Yu L, Fan G, Wang Q, Zhu Y, Zhu H, Chang J, et al. In vivo self-assembly and delivery of VEGFR2 siRNA-encapsulated small extracellular vesicles for lung metastatic osteosarcoma therapy. Cell Death Dis. 2023;14(9):626.","DOI":"10.1038\/s41419-023-06159-3"},{"issue":"7","key":"10.1016\/j.jbo.2026.100777_bb0470","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.70130","article-title":"(124)I-labelled BMSC-derived extracellular vesicles deliver CRISPR\/Cas9 ribonucleoproteins with a GFP-reporter system to inhibit osteosarcoma proliferation and metastasis","volume":"14","author":"Pan","year":"2025","journal-title":"J. Extracell. Vesicles"},{"key":"10.1016\/j.jbo.2026.100777_bb0475","doi-asserted-by":"crossref","unstructured":"Zhang M, Hu S, Liu L, Dang P, Liu Y, Sun Z, et al. Engineered exosomes from different sources for cancer-targeted therapy. Signal Transduct. Target. Ther. 2023;8(1):124.","DOI":"10.1038\/s41392-023-01382-y"},{"key":"10.1016\/j.jbo.2026.100777_bb0480","doi-asserted-by":"crossref","first-page":"107","DOI":"10.1016\/j.jconrel.2022.01.026","article-title":"Engineered exosome as targeted lncRNA MEG3 delivery vehicles for osteosarcoma therapy","volume":"343","author":"Huang","year":"2022","journal-title":"Journal of controlled release\u202f: official journal of the Controlled Release Society."},{"issue":"41","key":"10.1016\/j.jbo.2026.100777_bb0485","doi-asserted-by":"crossref","first-page":"56749","DOI":"10.1021\/acsami.5c12922","article-title":"Genetically engineered glycosylphosphatidylinositol-anchored anti-GD2 nanobody-exosome mimetics for targeted osteosarcoma therapy in vitro and in vivo","volume":"17","author":"Wang","year":"2025","journal-title":"ACS Appl. Mater. Interfaces"},{"issue":"5867","key":"10.1016\/j.jbo.2026.100777_bb0490","doi-asserted-by":"crossref","first-page":"1244","DOI":"10.1126\/science.1153124","article-title":"Ceramide triggers budding of exosome vesicles into multivesicular endosomes","volume":"319","author":"Trajkovic","year":"2008","journal-title":"Science (New York, N.Y.)"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0495","doi-asserted-by":"crossref","first-page":"5733","DOI":"10.1038\/s41467-021-25990-w","article-title":"A nanounit strategy reverses immune suppression of exosomal PD-L1 and is associated with enhanced ferroptosis","volume":"12","author":"Wang","year":"2021","journal-title":"Nat. Commun."},{"issue":"25","key":"10.1016\/j.jbo.2026.100777_bb0500","doi-asserted-by":"crossref","DOI":"10.1002\/adma.202400762","article-title":"Exosome-inhibiting polymeric sonosensitizer for tumor-specific sonodynamic immunotherapy","volume":"36","author":"Wu","year":"2024","journal-title":"Advanced materials (Deerfield Beach, Fla)."},{"key":"10.1016\/j.jbo.2026.100777_bb0505","doi-asserted-by":"crossref","first-page":"134","DOI":"10.1186\/1479-5876-10-134","article-title":"Exosome removal as a therapeutic adjuvant in cancer","volume":"10","author":"Marleau","year":"2012","journal-title":"J. Transl. Med."},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0510","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1186\/1479-5876-3-9","article-title":"A phase I study of dexosome immunotherapy in patients with advanced non-small cell lung cancer","volume":"3","author":"Morse","year":"2005","journal-title":"J. Transl. Med."},{"key":"10.1016\/j.jbo.2026.100777_bb0515","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/j.biomaterials.2016.09.031","article-title":"Exosome-based tumor antigens-adjuvant co-delivery utilizing genetically engineered tumor cell-derived exosomes with immunostimulatory CpG DNA","volume":"111","author":"Morishita","year":"2016","journal-title":"Biomaterials"},{"issue":"12","key":"10.1016\/j.jbo.2026.100777_bb0520","doi-asserted-by":"crossref","first-page":"2673","DOI":"10.1182\/blood-2008-04-153536","article-title":"Antigen-loaded exosomes alone induce Th1-type memory through a B-cell-dependent mechanism","volume":"113","author":"Qazi","year":"2009","journal-title":"Blood"},{"issue":"1","key":"10.1016\/j.jbo.2026.100777_bb0525","doi-asserted-by":"crossref","first-page":"10","DOI":"10.1186\/1479-5876-3-10","article-title":"Vaccination of metastatic melanoma patients with autologous dendritic cell (DC) derived-exosomes: results of thefirst phase I clinical trial","volume":"3","author":"Escudier","year":"2005","journal-title":"J. Transl. Med."},{"issue":"4","key":"10.1016\/j.jbo.2026.100777_bb0530","doi-asserted-by":"crossref","DOI":"10.1080\/2162402X.2015.1071008","article-title":"Dendritic cell-derived exosomes as maintenance immunotherapy after first line chemotherapy in NSCLC","volume":"5","author":"Besse","year":"2016","journal-title":"Oncoimmunology"},{"issue":"10","key":"10.1016\/j.jbo.2026.100777_bb0535","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12510","article-title":"A critical systematic review of extracellular vesicle clinical trials","volume":"13","author":"Mizenko","year":"2024","journal-title":"J. Extracell. Vesicles"},{"issue":"7","key":"10.1016\/j.jbo.2026.100777_bb0540","doi-asserted-by":"crossref","DOI":"10.1002\/jev2.12458","article-title":"A systematic review and meta-analysis of clinical trials assessing safety and efficacy of human extracellular vesicle-based therapy","volume":"13","author":"Van Delen","year":"2024","journal-title":"J. Extracell. Vesicles"}],"container-title":["Journal of Bone Oncology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000394?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2212137426000394?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,8,5]],"date-time":"2026-08-05T05:34:59Z","timestamp":1785908099000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2212137426000394"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,8]]},"references-count":108,"alternative-id":["S2212137426000394"],"URL":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100777","relation":{},"ISSN":["2212-1374"],"issn-type":[{"value":"2212-1374","type":"print"}],"subject":[],"published":{"date-parts":[[2026,8]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Extracellular vesicles in osteosarcoma: bridging resistance, immunity, and clinical translation","name":"articletitle","label":"Article Title"},{"value":"Journal of Bone Oncology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.jbo.2026.100777","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier GmbH.","name":"copyright","label":"Copyright"}],"article-number":"100777"}}